SCHEMBL2998543

SCHEMBL2998543

[Li]c1cccn1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL197196 0.69 PCSK9 (0.60)
SCHEMBL143814 0.67
SCHEMBL3766047 0.65
SCHEMBL8676817 0.65
SCHEMBL2971700 0.65
SCHEMBL3092636 0.65
SCHEMBL196709 0.65
SCHEMBL12074519 0.65
SCHEMBL12754884 0.65
SCHEMBL15272985 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100184977-A1 Nickel or Iron Catalysed Carbon-Carbon Coupling Reaction of Arylenes, Alkenes and Alkines SALTIGO GMBH (DE) 2010-07-22 US disclosed
CN-101300209-A Nickel-or iron-catalyzed carbon-carbon coupling of arylenes, alkenes and alkynes SALTIGO GMBH (DE) 2008-11-05 CN disclosed
EP-1924539-A1 NICKEL OR IRON CATALYSED CARBON-CARBON COUPLING REACTION OF ARYLENES, ALKENES AND ALKINES Saltigo GmbH (DE) 2008-05-28 EP disclosed
WO-2007031511-A1 NICKEL OR IRON CATALYSED CARBON-CARBON COUPLING REACTION OF ARYLENES, ALKENES AND ALKINES SALTIGO GMBH (DE) 2007-03-22 WO disclosed
US-6884801-B1 Imidazoline derivatives as alpha-1A adrenoceptor ligands SMITHKLINE BEECHAM CORPORATION (US) 2005-04-26 US disclosed
WO-2000061134-A9 ANTIMICROBIAL AGENTS BRITISH BIOTECH PHARM (GB) 2004-04-22 WO disclosed
US-6716878-B1 BACTERICIDE, ANTIPROTOZOAL; VANCOMYCIN RESISTANT ENTEROCOCCI AND BETA-LACTAM ANTIBIOTIC-RESISTANT BACTERIA, METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; HYDROXAMIC ACID AND N-FORMYL SUBTITUTED ALKYLAMIDES VERNALIS (OXFORD) LIMITED (GB) 2004-04-06 US disclosed
US-6509474-B1 Metallization with lithium in ether solvent in presence of conjugated diene hydrogen acceptor CHEMETALL GMBH (DE) 2003-01-21 US disclosed
EP-1124819-B1 METHOD OF LITHIATING FIVE-MEMBERED HETEROCYCLES CHEMETALL GMBH (DE) 2003-01-08 EP disclosed
EP-1169031-A1 ANTIMICROBIAL AGENTS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 2002-01-09 EP disclosed
WO-2000061134-A1 ANTIMICROBIAL AGENTS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 2000-10-19 WO disclosed
EP-0146348-B1 SUBSTITUTED NAPHTHALENES, INDOLES, BENZOFURANS AND BENZOTHIOPHENES AS LIPOXYGENASE INHIBITORS THE UPJOHN COMPANY (US) 1991-07-31 EP disclosed
US-4737519-A Substituted naphthalenes, indoles, benzofurans, and benzothiophenes as lipoxygenase inhibitors THE UPJOHN COMPANY (US) 1988-04-12 US disclosed
EP-0146348-A2 Substituted naphthalenes, indoles, benzofurans and benzothiophenes as lipoxygenase inhibitors THE UPJOHN COMPANY (US) 1985-06-26 EP disclosed
US-4173640-A Hypotensive perhydro naphthalene pentol derivatives E. R. SQUIBB & SONS, INC. (US) 1979-11-06 US disclosed